Results From St. Jude Medical’s Study Of Microvolt T-Wave Alternans To Be Presented At The 2006 American Heart Association Sessions

ST. PAUL, Minn., and BEDFORD, Mass.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) and Cambridge Heart, Inc. (OTCBB:CAMH) today announced that the findings of the Alternans Before Cardioverter Defibrillator (ABCD) clinical study will be presented at the American Heart Association (AHA) 2006 Annual Scientific Sessions in Chicago, Ill.